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Elongation rate and average length of amyloid
fibrils in solution using isotope-labelled
small-angle neutron scattering†
Ben J. Eves, a James J. Doutch,b Ann E. Terry,c Han Yin,a Martine Moulin,d
Michael Haertlein,d V. Trevor Forsyth,de Patrick Flagmeier, fg
Tuomas P. J. Knowles, fg David M. Dias,h Gudrun Lotze, c Annela M. Seddoni
and Adam M. Squires *a
We demonstrate a solution method that allows both elongation rate and average fibril length of
assembling amyloid fibrils to be estimated. The approach involves acquisition of real-time neutron
scattering data during the initial stages of seeded growth, using contrast matched buffer to make the
seeds effectively invisible to neutrons. As deuterated monomers add on to the seeds, the labelled
growing ends give rise to scattering patterns that we model as cylinders whose increase in length with
time gives an elongation rate. In addition, the absolute intensity of the signal can be used to determine
the number of growing ends per unit volume, which in turn provides an estimate of seed length. The
number of ends did not change significantly during elongation, demonstrating that any spontaneous or
secondary nucleation was not significant compared with growth on the ends of pre-existing fibrils, and
in addition providing a method of internal validation for the technique. Our experiments on initial growth of
alpha synuclein fibrils using 1.2 mg ml1 seeds in 2.5 mg ml1 deuterated monomer at room temperature
gave an elongation rate of 6.3  0.5 Å min1, and an average seed length estimate of 4.2  1.3 mm.
Introduction
Amyloid fibrils are microscopic fibers that can self-assemble
from a range of proteins and synthetic peptides. They have
received considerable attention due to their links with diseases
such as Alzheimer’s and Parkinson’s,1 but their study is also of
interest to further our understanding of the fundamental
thermodynamic and kinetic aspects of protein folding and
self-assembly, and as potential nanomaterials.
Amyloid fibril formation is greatly accelerated by the
addition of pre-formed ‘‘seeds’’. This phenomenon is considered
a model for prion disease propagation.2 In vitro seeding
experiments and their biological counterparts are of particular
interest in the study of polymorphic fibrils that show ‘‘strain’’
behavior, where the same protein can form fibrils with different
structures (‘‘polymorphs’’), and where the fibrils’ morphology in
seeding experiments is seemingly ‘‘inherited’’ from the ‘‘parent’’
seeds. Inherited fibril morphology through seeded growth is
thought to represent a mechanism for genetic inheritance in
yeast prions, and the brittleness of the fibrils and their growth
rate are both believed to play key roles in their physiological
impact.3 In the case of fibrils grown from biological seeds
extracted, for example, from brain samples, it has been shown
that the fibril structure can differ from that of the seeds,
suggesting that post-translational modification of a-synuclein
and/or additional molecules are necessary for filament
replication of seeds from disease in vivo.4
Currently, the most commonly used solution methods to
probe the kinetics of amyloid fibril growth are based on circular
dichroism or fluorescence spectroscopy, the latter based on
dye-binding; light/small-angle scattering; and chromatographic
approaches that monitor the decrease in the concentrations of
the precursor monomeric protein as it is incorporated into
growing fibrils.5–9 However, these techniques can only probe
the overall percentage of protein in the fibrillised form versus
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the unfibrillised form, and the rate of change of these percen-
tages. This rate of change is dependent on two different
variables which the techniques outlined above cannot separate:
the average rate of growth for a single amyloid fibril
(‘‘elongation rate’’), and the number (and length distribution)
of the amyloid fibrils. In the comparison of seeded growth
experiments from two different amyloid protein types, the
kinetics for one may be faster than the other, either because
the elongation of individual fibrils is faster, or because there is
a greater number of shorter fibrils present in the fibril seed
stock solution; the techniques cannot distinguish between the
two explanations.
Recent studies have aimed at the development of techniques
that can overcome these problems by directly measuring the
growth of individual amyloid fibrils. These studies have used
techniques such as quartz crystal microbalance sensors,10
atomic force microscopy (AFM),11 and total internal reflection
fluorescence microscopy.12 Single molecule techniques such as
AFM have begun to emerge as methods that allow direct
observation of the growth of amyloid fibrils and determination
of their elongation rates in situ. However, these techniques
also have their own limitations. A discrepancy between the
morphology of fibrils formed on a mica surface during AFM
experiments and fibrils formed in solution suggests that the
elongation rate of the amyloid fibrils on a mica surface would
not be representative of the fibril growth under solution
conditions. It has been suggested that fibril growth on surfaces
may be restricted. The surface properties of mica, such as
hydrophobicity, hydrophilicity and charge, are known to affect
the growth rate and morphology of the fibrils.13–15 Data can
also be hard to analyze if the scan rate of the AFM experiment is
close to or slower than the fibril growth rate. In addition, there
are concerns that the AFM measurement may influence the
kinetics through interactions with the probe tip.16
In order to determine the length of fibrils in the seed stock
solution, techniques such as transmission electron microscopy
(TEM) and AFM can be used to determine an average
length, which can be combined with overall transformation
measurements to determine elongation rates. However, these
length measurements often tend to be quite subjective due to
the selection of interpretable images for quantification.17,18
Furthermore, techniques such as TEM and AFM require the
removal of an aliquot of sample and extensive sample
preparation. Both techniques require deposition of a sample
onto a surface, washing of the surface, and subsequent drying.
If the measured length distribution is not representative of the
bulk, then the results will be skewed; this can occur when some
fibril lengths or polymorphs have a greater affinity to the
surface than others.19 Also, the drying process can affect the
morphology of the fibrils,20 and can disrupt fibrils into smaller
fragments, thereby giving an inaccurate representation of the
fibril lengths in the bulk solution.12
Here we present a new method to investigate elongation
rates during amyloid fibril growth in solution, and also to
determine the number (and hence average length) of the fibril
seeds. The method exploits small-angle neutron scattering
(SANS), used in conjunction with deuteration approaches.
Advanced methods for deuteration of proteins and other
macromolecules have been developed in the ILL’s Life Sciences
Group and are now widely applied in neutron applications
including SANS, crystallography, reflectometry and dynamics.21–29
In the method we present here, neutron scattering patterns from
deuterated growing ends are modelled as rods. The increasing
lengths of the rods can then be determined over time and used to
calculate an elongation rate for an individual fibril. In addition, the
average length of the initial fibril seeds can be calculated, since the
concentration of the rods is a measure of the concentration of
fibril ends.
The information yielded from this SANS/deuteration
methodology will be vital in improving the mechanistic under-
standing of amyloid and prion diseases, whilst also furthering
the foundation of the theoretical understanding of peptide
fibrillation kinetics based on molecular models.
Results and discussion
Seed characterization
First, a model of the fibrils dimensions was created, for use in
subsequent analysis, using the scattering arising from hydro-
genated a-synuclein seeds in a contrasting deuterated solution.
A cylinder model was used to fit the scattering curve from the
1.2 mg ml1 hydrogenated a-synuclein fibril seeds in 80% D2O
(Fig. 1).30 The model corresponds to a cylinder with radius
constrained to be 60 Å (based on TEM measurements, ESI,†
Fig. S1), and length that was allowed to vary in the fitting
process. This analysis effectively returned infinite lengths,
since a SANS experiment can typically only resolve length scales
up to 1000 Å. A mean diameter of 120  20 Å (n = 100) and a
mean length of 2790  1250 Å (n = 66) was calculated from TEM
(Fig. S1, ESI†). a-Synuclein seed fibrils exhibited a ‘twisted’
morphology and other distinct fibril morphologies were not
observed. The agreement between the experimental data and
the fit is reasonable. At low Q there is a divergence of the
experimental data from the model, which could be attributed to
higher order aggregation such as fibril–fibril association.31
In addition to providing a model for subsequent analysis,
the scattering curve from the seeds can be used to determine
the mass-per-unit-length (MPUL) of the a-synuclein fibrils; a
parameter that can differentiate between fibril morphologies
and provides insight into the structure. The MPUL can be
calculated by first determining the y-intercept Ic(0) of a modified
Guinier plot (ESI†), arising from hydrogenated a-synuclein fibril
seed scattering (9.0 0.5 104 cm1 Å1) and applying it to the
following equation:16
M ¼ 1000Ic 0ð Þd
2NA
pC rp  rs
 2
where M is the mass-per-unit-length of the fibril, d is the mean
density of a protein (1.35 g ml1), NA is Avogadro’s number
(6.022  1023 mol1), C is the concentration of protein in the
fibril seeds (1.2 mg ml1),32 rp is the scattering length density of
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the fibril seeds (2.77  1010 cm2) and rs is the scattering length
density of the solvent (4.99  1010 cm2). The fibril scattering
length density was calculated from the atomic composition of
a-synuclein using the ISIS Biomolecular Scattering Length
Density Calculator program (http://psldc.isis.rl.ac.uk/Psldc/).
Using these values, the mass-per-unit-length of the a-synuclein
fibrils was determined to be 4800  300 Da Å1. Dearborn et al.
used cryo-electron microscopy and scanning transmission electron
microscopy (STEM) to investigate a-synuclein fibrils reporting a
mean mass-per-unit-length of 5910 Da Å1.33 There is reasonable
agreement between the mass-per-unit-length determined by STEM
and SANS.
Elongation rates
Elongation experiments were performed in a solution containing
1.2 mg ml1 hydrogenated seeds and 2.5 mg ml1 deuterated
monomer, in buffer containing 40% D2O, which contrast-
matched the seeds (see ESI,† Fig. S3). As deuterated a-synuclein
grew on the seed ends, the contrast with the solution gave rise to
scattering signals (Fig. 2). The patterns were modelled as cylinders
of radius 60 Å obtained as described in the previous section, and
the length was allowed to vary as a fittable parameter. The best
fits obtained over the range Q = [0.00562 to 0.07119 Å1] for
experiment 1 and Q = [0.0052 to 0.07688 Å1] for experiment 2 are
also included in Fig. 2.
The fits to the patterns from the deuterated a-synuclein ends
give length values at subsequent time points, from which we
obtain an averaged plot of length versus time (Fig. 3). A linear
elongation rate can be extracted from the slope of the linear fit.
The linear extension rate for a-synuclein fibrils was found to be
7.0  0.8 Å min1 in the first experiment and 5.6  0.5 Å min1
in the second experiment, giving an average of 6.3 0.5 Å min1
(20 mM phosphate buffer, pH 7.4, 25 1C, monomer concen-
tration 2.5 mg ml1). This result is in reasonable agreement
with other reported elongation rates of amyloid fibrils. Buell
and co-workers reported an average elongation rate of
B10 Å min1 for a-synuclein fibrils (20 mM phosphate buffer,
pH 7.4, 37 1C, monomer concentration 0.29 mg ml1) measured
with fluorescence kinetics, with seed lengths determined by
AFM, whilst Wördehoff and colleagues reported an elongation
rate of 85  37 Å min1 for a-synuclein fibrils measured using
total internal reflection fluorescence microscopy (20 mM 2-(N-
morpholino) ethanesulfonic acid (MES) buffer, pH 6.0, 25 1C,
monomer concentration 2.3 mg ml1).34,35 Although our
numerical value is similar to those of Buell et al., the conditions
are not exactly comparable: our results were obtained at an
Fig. 1 (top) Hydrogenated a-synuclein fibril seeds (1.2 mg ml1) in 80%
D2O (Sodium phosphate HPCE buffer pH 7.4, 10 mM) with cylinder fit,
radius 60 Å. (bottom) TEM image of a-synuclein fibril seeds. Scale bar
represents 5000 Å.
Fig. 2 Repeat experiments showing kinetic SANS of hydrogenated a-synuclein fibril seeds at concentration 1.2 mg ml1 after mixing with 2.5 mg ml1
deuterated a-synuclein monomers (data points) in buffer contrast-matched to seeds; fits to patterns from growing deuterated ends at subsequent time
points modelled as cylinders of radius 60 Å and variable lengths (solid lines).
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order of magnitude higher monomer concentration, but at
25 1C rather than 37 1C. Our results are an order of magnitude
slower than Wördehoff’s, but were obtained at pH 7.4 rather
than 6.0, which Buell et al. suggest causes an order of
magnitude decrease in elongation rate.34 The good agreement
between elongation values from both of the kinetic experiments
suggests the data from the SANS contrast matching technique
is reproducible.
The good fit to a single cylinder length at each timepoint
suggests that the growing ends are growing at the same rate.
Fibril ends growing at different rates would show a worse fit to
a single cylinder length, and would require fitting to the sum of
two cylinder populations. For this situation we would be able to
measure both elongation rates of the ends. Within the noise,
we do not detect a difference in the rate of growth for each end.
Concentrations of fibril ends
In addition to the linear extension rate, parameters such as
concentrations of fibril ends and hence seed sizes can be
extracted and validated using the kinetic SANS of a-synuclein
fibrils. Using these values, it is possible to validate the elongation
rate and monitor secondary kinetic processes.
The SANS coherent macroscopic scattering cross section for















is the number density of particles, Vp is the volume
of the particle, Dr2 is the contrast factor, P(Q) is the form factor
and S(Q) is the structure factor.
For the case where Q = 0 and the solution is dilute, P(Q) = 1
and S(Q) = 1. The equation above simplifies to:36,37





where I(0) is the scattering intensity at the zero angle.
As I(0) p Vp
2, if the length of the seeds increases linearly
with time then I(0) will have a squared relationship with time.
The values of I(0) for each time point in the SANS kinetic
experiment can be determined from a Guinier plot. Furthermore,
using values for length of labelled ends obtained from the
cylindrical curve fits (Fig. 2 and 3), a plot of length2 versus I(0)
will give a linear relationship.





or Dr2. As there is not significant deviation from the
expected relationships (Fig. 4), it can be inferred that there is




over the time course of





, the number of growing, labelled ends per unit
volume. This would appear to argue against any significant
breakage or secondary nucleation during the experiment within
experimental error. The system can therefore be treated as a
fixed number of growing ends.
Although the overall fibril seed length is too long to
determine directly by the experiment, the average length can
be estimated from the kinetic SANS data and the hydrogenated
a-synuclein fibril seed scattering, using the fibril seed concen-
tration, the mass-per-unit-length (MPUL) of the seed fibrils and
the number density of seeds. The fibril seed concentration
(in mg ml1) is already known from the experimental preparation,
and the MPUL of the seed fibrils was calculated previously
using the non-matched hydrogenated a-synuclein fibril seed
scattering (ESI†).
Fig. 3 Plot of length versus time for a-synuclein fibril seed elongation.
Length values were obtained from averaged cylindrical fits to data shown
in Fig. 2.
Fig. 4 (top) Plot of I(0) versus time for a-synuclein fibril seed elongation.
(bottom) Plot of length2 versus I(0) for a-synuclein fibril seed elongation.





























































































determined previously gives an estimate







If the growth of the fibril ends is assumed to be bidirectional,
as previously suggested, then there will be two growing ends for














Using the number density of the seeds, the known concen-
tration of seeds and the MPUL, the following equation gives an




SL is the fibril seed length (Å), C is the concentration of fibril
seeds (mg ml1), M is the mass-per-unit-length of the hydro-
genated fibrils (g Å1), and Ns is the number density of seeds.
The fibril seed lengths were estimated to be 3.9  1.8 mm
from the first kinetic run and 4.5  1.9 mm from the second
kinetic run, giving an average of 4.2  1.3 mm. Fibril seed
lengths determined by TEM (S1) gave a mean length of 280 
120 nm (n = 66). We speculate two possible reasons for this
discrepancy: it is possible that not all of the fibril seed ends are
active and accessible for growth (in our SANS experiment),
which would lead to an underestimate of the number of ends,
and therefore an overestimate of the average seed length;
conversely, it is possible that the TEM is under-estimating the
fibril seed lengths, either because sample preparation and
dehydration for TEM experiments induces breakage, or because
shorter fibril seeds have greater affinity for TEM grids than
longer seeds, skewing the length estimate.
At later timepoints where the fibril ends are approaching a Q
range where the length appears ‘‘infinite’’ i.e. is much greater
than the interrogated Q space of the experiment, the error in
determining the length of the growing ends, and I(0) increases
inducing a large uncertainty in the estimation of the fibril seed
lengths.
Conclusions
This technique outlined here provided a new way of measuring
amyloid fibril elongation rates. The average elongation rate of
a-synuclein fibrils was determined to be 6.3  0.5 Å min1. The
values reported by this procedure corresponded to results from
previous research measured using fluorescence kinetics, where
measurements were performed in solution (B10 Å min1)
using an independent estimate of seed length obtained by
TEM.34 Elongation measured on surfaces using total
internal reflection fluorescence microscopy was faster (85 
37 Å min1).35 Our technique does not require knowledge of
seed lengths to determine elongation rate. Furthermore, as the
technique utilizes solution scattering it does not require dye
binding, nor does the sample have to be immobilized on a
surface; these conditions are required for fluorescence kinetics
and total internal reflection fluorescence microscopy and may
influence the elongation rate.13,34,35,39
The technique is reasonably universal, and is currently
limited by signal:noise, which will be overcome by increasingly
powerful neutron sources. In the current experiment, these
considerations prevent shorter acquisition times, which means
that we would not be able to study fibrils with a greater
elongation rate, such that sufficient scattering of the sample
cannot be collected before the fibril lengths are too long to be
accurately measured by SANS. The technique can in principle
be applied to samples with structural polymorphism as the
observed scattering patterns are a linear combination of
scattering from each species. For example, if there were two
polymorphs growing at different rates, it would be possible to
fit the scattering patterns to two populations of cylinders and
measure an elongation rate for each. This potential would
represent an advantage over dye-binding or CD spectroscopic
methods, where only a single value is obtained for both species.
However, to realise this potential for SANS requires much
greater signal:noise from a brighter neutron beam.
In addition, the data also provide an estimate of the number
concentration of fibril ends and thus the average fibril length.
The technique is applicable even for fibrils that are long,
flexible and/or intrinsically curved, factors that present a
challenge to other methods of estimating length.
With these two measurements, neutron scattering presents
powerful tools to study dynamics of fibril formation, directly
determining different contributions from breakage and elongation
rates, and ultimately helping to shed light on amyloid processes
involving disease and other prion strain propagation contexts.
Experimental
Protein production
a-Synuclein (hydrogenated and perdeuterated) was produced
recombinantly in the PSB Deuteration Laboratory (D-LAB) platform
within the Life Sciences Group at the ILL.21 A kanamycin resistant
expression system coding for a-synuclein was transformed
into BL21(DE3) cells. A high-cell density fed-batch culture using
d8-glycerol (Euriso-top) as a carbon source was then carried out
using a computer-controlled protocol at a temperature of 30 1C, a
pD of 6.9, and a pO2 of 30% saturation. a-Synuclein expression was
induced with 0.2 mM isopropyl thiogalactopyranoside and the
deuterated protein purified as described previously.40 The protein
was used as a lyophilized powder.
Amyloid fibril formation
a-Synuclein fibril formation was based on a previously
described method.34 a-synuclein was dissolved in 20 mM
sodium phosphate buffer HPCE pH 7.4 (Sigma Aldrich, UK)
to give 500 mL aliquots at a final concentration of 500 mM.
The solutions containing a micro polytetrafluoroethylene
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magnetic stirrer bar (Fisherbrand, UK) were incubated for 72 h
at 40 1C with maximal stirring on a RCT Basic heat plate (IKA,
Staufen, Germany).
Amyloid seed generation
Amyloid fibril ‘seeds’ were generated using a liquid nitrogen
freeze/thaw process repeated three times.41 The freeze/thaw
process consisted of Eppendorf tubes containing 500 mL of
amyloid fibrils being plunged into liquid nitrogen for 5 min
before being removed and placed into a beaker of water
to thaw.
Transmission electron microscopy
TEM imaging was carried out using a JEOL JEM-2100 Plus
(JEOL, Tokyo, Japan) operating at 200 kV. Samples were
prepared using a previously reported method.42 Amyloid fibril
seed solutions were first diluted to 0.01–0.5 mg ml1 in Milli-Q
water, before a small aliquot (5 mL) was pipetted onto a
300-mesh carbon-coated copper grid that had been glow
discharged. The solution was left to adsorb for 30 s before a
wedge of filter paper was used to wick the solution off the
copper grid. The grid was then rinsed with distilled H2O after
which an aliquot of 2% (w/v) uranyl acetate was applied and left
to stain for 30 s. The stain was then wicked away using filter
paper and the sample was left to air dry.
Small angle neutron scattering, SANS2D, ISIS
SANS measurements were carried out at ambient temperature
on the second-generation time-of-flight SANS2D instrument at
ISIS (Harwell, UK). Sample solutions were measured in disc-
shaped (‘‘banjo’’) quartz cells with a path length of 1 mm held
in a rotating sample changer. An incident wavelength range of
2–14 Å with a sample-to-detector distance of 4 m, gave a Q range
of Qmin = 0.002 Å
1 Qmax = 3 Å1. The SANS data collected was
corrected for transmission, background, and pixel sensitivity of
the 2-D detector, and averaged into a 1-D function, I(Q). Data
was then scaled to absolute intensity for the scattering cross
section per unit sample volume (cm1) using Mantid.43 Data
analysis and modelling was performed in SASView.44
Small angle neutron scattering kinetics. A solution containing
hydrogenated a-synuclein seeds 1.2 mg ml1 and deuterated
a-synuclein monomer 2.5 mg ml1 in 40% D2O (sodium phos-
phate HPCE buffer pH 7.4, 10 mM) was mixed, transferred to a
rotating ‘‘banjo’’ cell (250 mL) and immediately measured at
ambient temperature with an acquisition time of 4 h. Data were
sliced into 30 min time slices using Mantid.43
Fitting small angle neutron scattering data. TEM images
were used initially as a guide to particle shape for a-synuclein
fibrils. A cylinder model utilizing as constraints dimensions
determined from TEM images was used as the basis of the
model applied to the SANS data. SASView was then used to
optimize the model and improve the ‘‘goodness of fit’’.44 The
reduced chi-squared values from SASView were used as a
measure of the ‘‘goodness of fit’’; this parameter is related to
the difference between the experimental data and the model.
For a good fit to the data, the value of the reduced chi-squared
will tend to 1.
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